Synthace
Company

Last deal

$35.M

Amount

Series C

Stage

16.11.2021

Date

13

all rounds

$79.9M

Total amount

General

About Company
Synthace is a life sciences R&D cloud platform that automates experiments and integrates data.

Industry

Sector :

Subsector :

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

Synthace's Antha operating system for biology allows easy design and optimization of biological unit operations, linking them into executable workflows that are reliable, shareable, and saleable. The platform removes the wrangling of lab data through dynamic generation, capture, and structuring of data with metadata, and helps plan and execute multi-factorial experiments. Biologists can conduct codeless reprogramming of liquid handlers and visual stimulation before executing experiments, enabling them to innovate faster and unlock the true potential of biology.
Contacts